Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
7.68
+0.12 (1.59%)
At close: Oct 24, 2024, 4:00 PM
8.00
+0.32 (4.17%)
After-hours: Oct 24, 2024, 5:25 PM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $480.39 million as of October 24, 2024. Its market cap has increased by 591.21% in one year.
Market Cap
480.39M
Enterprise Value
426.34M
1-Year Change
591.21%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $480.39M, an increase of 65.20%. That is a compound annual growth rate of 6.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 472.90M | 447.97% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auna S.A. | 513.73M |
| Varex Imaging | 512.40M |
| Emergent BioSolutions | 498.60M |
| Pacific Biosciences of California | 490.55M |
| PureTech Health | 485.44M |
| Altimmune | 483.28M |
| Verve Therapeutics | 481.51M |
| Talkspace | 481.09M |